Year None202320222021202020192018201720162015201420132012 11.02.2022 Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 10.27.2022 Iveric Bio to Report Third Quarter 2022 Financial Results and Host Conference Call on Thursday, November 3, 2022 10.04.2022 Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 09.27.2022 Iveric Bio to Present Top-line Results for Avacincaptad Pegol from Phase 3 GATHER2 Clinical Trial in Geographic Atrophy at AAO 2022 Annual Meeting 09.07.2022 Iveric Bio to Present at Upcoming Investor Conferences 09.06.2022 Iveric Bio Announces Positive Topline Data from Zimura® GATHER2 Phase 3 Clinical Trial in Geographic Atrophy 09.02.2022 Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 08.10.2022 Iveric Bio to Participate in the H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference 08.03.2022 Iveric Bio to Present at the Wedbush PacGrow Healthcare Conference 2022 08.02.2022 Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Pagination First page « first Previous page ‹ previous Page 1 Current page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last »
